Selected research
Market Analysis & Forecast
Global Anatomic Pathology Equipment Market Analysis and Forecast 2026-2032
Market perspective
The global Anatomic Pathology Equipment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Anatomic Pathology Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Anatomic Pathology Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Anatomic Pathology Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Anatomic Pathology Equipment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Anatomic Pathology Equipment include Leica Biosystems, Roche Diagnostics, Agilent, Epredia, Sakura Seiki, Biocare Medical, BioGenex, Fuzhou Maixin Biotech and PathnSitu Biotechnologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Anatomic Pathology Equipment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Anatomic Pathology Equipment, also provides the revenue of main regions and countries. Of the upcoming market potential for Anatomic Pathology Equipment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anatomic Pathology Equipment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anatomic Pathology Equipment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anatomic Pathology Equipment revenue, projected growth trends, production technology, application and end-user industry.
Anatomic Pathology Equipment Segment by Company
Leica Biosystems
Roche Diagnostics
Agilent
Epredia
Sakura Seiki
Biocare Medical
BioGenex
Fuzhou Maixin Biotech
PathnSitu Biotechnologies
Sophonix
Anbiping
Yaneng BIO
ADS Biotec
Attobio
Anatomic Pathology Equipment Segment by Type
Slide Staining Systems
Tissue Processing Systems
Cell Processors
Microtomes
Embedded Systems
Coverslippers
Other
Anatomic Pathology Equipment Segment by Application
Hospital
Diagnostic Centers
R&D Lab
Anatomic Pathology Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anatomic Pathology Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anatomic Pathology Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anatomic Pathology Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Anatomic Pathology Equipment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Anatomic Pathology Equipment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anatomic Pathology Equipment revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- Microtomes
- Embedded Systems
- Coverslippers
- Other
Applications
- Hospital
- Diagnostic Centers
- R&D Lab
Companies covered
- Leica Biosystems
- Roche Diagnostics
- Agilent
- Epredia
- Sakura Seiki
- Biocare Medical
- BioGenex
- Fuzhou Maixin Biotech
- PathnSitu Biotechnologies
- Sophonix
- Anbiping
- Yaneng BIO
- ADS Biotec
- Attobio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Anatomic Pathology Equipment Market by Type
- 1.2.1 Global Anatomic Pathology Equipment Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Slide Staining Systems
- 1.2.3 Tissue Processing Systems
- 1.2.4 Cell Processors
- 1.2.5 Microtomes
- 1.2.6 Embedded Systems
- 1.2.7 Coverslippers
- 1.2.8 Other
- 1.3 Anatomic Pathology Equipment Market by Application
- 1.3.1 Global Anatomic Pathology Equipment Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Diagnostic Centers
- 1.3.4 R&D Lab
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Anatomic Pathology Equipment Market Dynamics
- 2.1 Anatomic Pathology Equipment Industry Trends
- 2.2 Anatomic Pathology Equipment Industry Drivers
- 2.3 Anatomic Pathology Equipment Industry Opportunities and Challenges
- 2.4 Anatomic Pathology Equipment Industry Restraints
3 Global Growth Perspective
- 3.1 Global Anatomic Pathology Equipment Market Perspective (2021-2032)
- 3.2 Global Anatomic Pathology Equipment Growth Trends by Region
- 3.2.1 Global Anatomic Pathology Equipment Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Anatomic Pathology Equipment Market Size by Region (2021-2026)
- 3.2.3 Global Anatomic Pathology Equipment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Anatomic Pathology Equipment Revenue by Players
- 4.1.1 Global Anatomic Pathology Equipment Revenue by Players (2021-2026)
- 4.1.2 Global Anatomic Pathology Equipment Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Anatomic Pathology Equipment Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Anatomic Pathology Equipment Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Anatomic Pathology Equipment Key Players Headquarters & Area Served
- 4.4 Global Anatomic Pathology Equipment Players, Product Type & Application
- 4.5 Global Anatomic Pathology Equipment Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Anatomic Pathology Equipment Market CR5 and HHI
- 4.6.3 2025 Anatomic Pathology Equipment Tier 1, Tier 2, and Tier 3
5 Anatomic Pathology Equipment Market Size by Type
- 5.1 Global Anatomic Pathology Equipment Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Anatomic Pathology Equipment Revenue by Type (2021-2032)
- 5.3 Global Anatomic Pathology Equipment Revenue Market Share by Type (2021-2032)
6 Anatomic Pathology Equipment Market Size by Application
- 6.1 Global Anatomic Pathology Equipment Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Anatomic Pathology Equipment Revenue by Application (2021-2032)
- 6.3 Global Anatomic Pathology Equipment Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Leica Biosystems
- 7.1.1 Leica Biosystems Company Information
- 7.1.2 Leica Biosystems Business Overview
- 7.1.3 Leica Biosystems Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.1.4 Leica Biosystems Anatomic Pathology Equipment Product Portfolio
- 7.1.5 Leica Biosystems Recent Developments
- 7.2 Roche Diagnostics
- 7.2.1 Roche Diagnostics Company Information
- 7.2.2 Roche Diagnostics Business Overview
- 7.2.3 Roche Diagnostics Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.2.4 Roche Diagnostics Anatomic Pathology Equipment Product Portfolio
- 7.2.5 Roche Diagnostics Recent Developments
- 7.3 Agilent
- 7.3.1 Agilent Company Information
- 7.3.2 Agilent Business Overview
- 7.3.3 Agilent Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.3.4 Agilent Anatomic Pathology Equipment Product Portfolio
- 7.3.5 Agilent Recent Developments
- 7.4 Epredia
- 7.4.1 Epredia Company Information
- 7.4.2 Epredia Business Overview
- 7.4.3 Epredia Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.4.4 Epredia Anatomic Pathology Equipment Product Portfolio
- 7.4.5 Epredia Recent Developments
- 7.5 Sakura Seiki
- 7.5.1 Sakura Seiki Company Information
- 7.5.2 Sakura Seiki Business Overview
- 7.5.3 Sakura Seiki Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.5.4 Sakura Seiki Anatomic Pathology Equipment Product Portfolio
- 7.5.5 Sakura Seiki Recent Developments
- 7.6 Biocare Medical
- 7.6.1 Biocare Medical Company Information
- 7.6.2 Biocare Medical Business Overview
- 7.6.3 Biocare Medical Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.6.4 Biocare Medical Anatomic Pathology Equipment Product Portfolio
- 7.6.5 Biocare Medical Recent Developments
- 7.7 BioGenex
- 7.7.1 BioGenex Company Information
- 7.7.2 BioGenex Business Overview
- 7.7.3 BioGenex Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.7.4 BioGenex Anatomic Pathology Equipment Product Portfolio
- 7.7.5 BioGenex Recent Developments
- 7.8 Fuzhou Maixin Biotech
- 7.8.1 Fuzhou Maixin Biotech Company Information
- 7.8.2 Fuzhou Maixin Biotech Business Overview
- 7.8.3 Fuzhou Maixin Biotech Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.8.4 Fuzhou Maixin Biotech Anatomic Pathology Equipment Product Portfolio
- 7.8.5 Fuzhou Maixin Biotech Recent Developments
- 7.9 PathnSitu Biotechnologies
- 7.9.1 PathnSitu Biotechnologies Company Information
- 7.9.2 PathnSitu Biotechnologies Business Overview
- 7.9.3 PathnSitu Biotechnologies Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.9.4 PathnSitu Biotechnologies Anatomic Pathology Equipment Product Portfolio
- 7.9.5 PathnSitu Biotechnologies Recent Developments
- 7.10 Sophonix
- 7.10.1 Sophonix Company Information
- 7.10.2 Sophonix Business Overview
- 7.10.3 Sophonix Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.10.4 Sophonix Anatomic Pathology Equipment Product Portfolio
- 7.10.5 Sophonix Recent Developments
- 7.11 Anbiping
- 7.11.1 Anbiping Company Information
- 7.11.2 Anbiping Business Overview
- 7.11.3 Anbiping Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.11.4 Anbiping Anatomic Pathology Equipment Product Portfolio
- 7.11.5 Anbiping Recent Developments
- 7.12 Yaneng BIO
- 7.12.1 Yaneng BIO Company Information
- 7.12.2 Yaneng BIO Business Overview
- 7.12.3 Yaneng BIO Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.12.4 Yaneng BIO Anatomic Pathology Equipment Product Portfolio
- 7.12.5 Yaneng BIO Recent Developments
- 7.13 ADS Biotec
- 7.13.1 ADS Biotec Company Information
- 7.13.2 ADS Biotec Business Overview
- 7.13.3 ADS Biotec Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.13.4 ADS Biotec Anatomic Pathology Equipment Product Portfolio
- 7.13.5 ADS Biotec Recent Developments
- 7.14 Attobio
- 7.14.1 Attobio Company Information
- 7.14.2 Attobio Business Overview
- 7.14.3 Attobio Anatomic Pathology Equipment Revenue and Gross Margin (2021-2026)
- 7.14.4 Attobio Anatomic Pathology Equipment Product Portfolio
- 7.14.5 Attobio Recent Developments
8 North America
- 8.1 North America Anatomic Pathology Equipment Revenue (2021-2032)
- 8.2 North America Anatomic Pathology Equipment Revenue by Type (2021-2032)
- 8.2.1 North America Anatomic Pathology Equipment Revenue by Type (2021-2026)
- 8.2.2 North America Anatomic Pathology Equipment Revenue by Type (2027-2032)
- 8.3 North America Anatomic Pathology Equipment Revenue Share by Type (2021-2032)
- 8.4 North America Anatomic Pathology Equipment Revenue by Application (2021-2032)
- 8.4.1 North America Anatomic Pathology Equipment Revenue by Application (2021-2026)
- 8.4.2 North America Anatomic Pathology Equipment Revenue by Application (2027-2032)
- 8.5 North America Anatomic Pathology Equipment Revenue Share by Application (2021-2032)
- 8.6 North America Anatomic Pathology Equipment Revenue by Country
- 8.6.1 North America Anatomic Pathology Equipment Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Anatomic Pathology Equipment Revenue by Country (2021-2026)
- 8.6.3 North America Anatomic Pathology Equipment Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Anatomic Pathology Equipment Revenue (2021-2032)
- 9.2 Europe Anatomic Pathology Equipment Revenue by Type (2021-2032)
- 9.2.1 Europe Anatomic Pathology Equipment Revenue by Type (2021-2026)
- 9.2.2 Europe Anatomic Pathology Equipment Revenue by Type (2027-2032)
- 9.3 Europe Anatomic Pathology Equipment Revenue Share by Type (2021-2032)
- 9.4 Europe Anatomic Pathology Equipment Revenue by Application (2021-2032)
- 9.4.1 Europe Anatomic Pathology Equipment Revenue by Application (2021-2026)
- 9.4.2 Europe Anatomic Pathology Equipment Revenue by Application (2027-2032)
- 9.5 Europe Anatomic Pathology Equipment Revenue Share by Application (2021-2032)
- 9.6 Europe Anatomic Pathology Equipment Revenue by Country
- 9.6.1 Europe Anatomic Pathology Equipment Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Anatomic Pathology Equipment Revenue by Country (2021-2026)
- 9.6.3 Europe Anatomic Pathology Equipment Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Anatomic Pathology Equipment Revenue (2021-2032)
- 10.2 China Anatomic Pathology Equipment Revenue by Type (2021-2032)
- 10.2.1 China Anatomic Pathology Equipment Revenue by Type (2021-2026)
- 10.2.2 China Anatomic Pathology Equipment Revenue by Type (2027-2032)
- 10.3 China Anatomic Pathology Equipment Revenue Share by Type (2021-2032)
- 10.4 China Anatomic Pathology Equipment Revenue by Application (2021-2032)
- 10.4.1 China Anatomic Pathology Equipment Revenue by Application (2021-2026)
- 10.4.2 China Anatomic Pathology Equipment Revenue by Application (2027-2032)
- 10.5 China Anatomic Pathology Equipment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Anatomic Pathology Equipment Revenue (2021-2032)
- 11.2 Asia Anatomic Pathology Equipment Revenue by Type (2021-2032)
- 11.2.1 Asia Anatomic Pathology Equipment Revenue by Type (2021-2026)
- 11.2.2 Asia Anatomic Pathology Equipment Revenue by Type (2027-2032)
- 11.3 Asia Anatomic Pathology Equipment Revenue Share by Type (2021-2032)
- 11.4 Asia Anatomic Pathology Equipment Revenue by Application (2021-2032)
- 11.4.1 Asia Anatomic Pathology Equipment Revenue by Application (2021-2026)
- 11.4.2 Asia Anatomic Pathology Equipment Revenue by Application (2027-2032)
- 11.5 Asia Anatomic Pathology Equipment Revenue Share by Application (2021-2032)
- 11.6 Asia Anatomic Pathology Equipment Revenue by Country
- 11.6.1 Asia Anatomic Pathology Equipment Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Anatomic Pathology Equipment Revenue by Country (2021-2026)
- 11.6.3 Asia Anatomic Pathology Equipment Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Anatomic Pathology Equipment Revenue (2021-2032)
- 12.2 SAMEA Anatomic Pathology Equipment Revenue by Type (2021-2032)
- 12.2.1 SAMEA Anatomic Pathology Equipment Revenue by Type (2021-2026)
- 12.2.2 SAMEA Anatomic Pathology Equipment Revenue by Type (2027-2032)
- 12.3 SAMEA Anatomic Pathology Equipment Revenue Share by Type (2021-2032)
- 12.4 SAMEA Anatomic Pathology Equipment Revenue by Application (2021-2032)
- 12.4.1 SAMEA Anatomic Pathology Equipment Revenue by Application (2021-2026)
- 12.4.2 SAMEA Anatomic Pathology Equipment Revenue by Application (2027-2032)
- 12.5 SAMEA Anatomic Pathology Equipment Revenue Share by Application (2021-2032)
- 12.6 SAMEA Anatomic Pathology Equipment Revenue by Country
- 12.6.1 SAMEA Anatomic Pathology Equipment Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Anatomic Pathology Equipment Revenue by Country (2021-2026)
- 12.6.3 SAMEA Anatomic Pathology Equipment Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst